GLP-1 (7–37)
Metabolic
PreclinicalIt is primarily a native peptide research tool and physiologic reference.
Laboratory, computational, ex vivo or animal model research is the main evidence base.
What is GLP-1 (7–37)?
GLP‑1 (7–37) is the native incretin peptide used as a physiological reference and research tool in metabolic studies; the catalogue item denotes the research grade native peptide sequence.
Which research context has GLP-1 (7–37) been associated with?
GLP-1 (7–37) is associated with metabolic research as the native incretin peptide used as a physiological reference and research tool in studies of glucagon like peptide 1 receptor signalling, insulinotropic pathways and incretin biology in cellular and animal models.
What documentation is available for GLP-1 (7–37)?
GLP-1 (7–37): Batch documents are not yet linked on this site. For this endogenous incretin peptide used as a research tool the checklist includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity specification; peptide content and residual solvent/water declaration; and relevant assay or bioactivity data. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for GLP-1 (7–37)?
GLP-1 (7–37): Storage depends on the documented supplied presentation; as an endogenous incretin peptide verify dry/lyophilised versus solution form, counterion and concentration, solvent or buffer selection, pH sensitivity, container closure compatibility and proteolytic or aggregation risks affecting stability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.